Freeway
Arizona

Tucson

Data as of Oct 1, 2026
715
Companies
$10.0M
Venture funding in the last 12 months, 2 rounds
$94.7M
Venture funding, 2022–2026
32
Investor firms

Venture funding by year

* 2026 through Oct 2026. Rounds without a disclosed amount count as rounds, not dollars.
Show as a table
YearVenture fundingRounds
2019$14.1M12
2020$29.2M11
2021$19.9M11
2022$35.6M9
2023$3.7M7
2024$28.2M11
2025$17.2M6
2026*$10.0M2

Industries

  • Health126
  • Energy46
  • Education37
  • Semiconductors37
  • Fintech34
  • Food30
  • Enterprise software29
  • Real estate26
  • Kids22
  • Security17

And 19 more industries.

Companies in Tucson

121–144 of 715 companies

  • Early stage · 2–10 employees

  • Early stage · 11–50 employees

  • Capstone Horizon

    Jobs & recruitment

    Capstone Horizon LLC is a service-disabled veteran-owned small business (SDVOSB) that operates at the intersection of software development, talent acquisition, and program management for the U.S. federal contracting market. Headquartered in Arizona with operational presence in Nevada, the company holds certifications as a HUBZone and Hispanic-American-Owned business. The company's business model is built on three vertically integrated pillars. The first is AI-native software, centered around its flagship SaaS platform, DeployReady. This tool is designed for government contractors to analyze federal solicitations, access pricing intelligence based on public award data, and automate the generation of compliant proposal drafts. The platform is specifically engineered to avoid processing sensitive government data like FCI or CUI, positioning it as an external tool for proposal preparation. The second pillar is a talent practice focused on placing technical and cleared professionals within federal programs. This service line complements its software and program management offerings. The third pillar is providing direct program management services to federal agencies and prime contractors. This integrated approach allows Capstone Horizon to serve a diverse client base, including federal agencies, prime contractors, and mid-market government suppliers, by offering a blend of technology and specialized human capital.

    Early stage

  • Early stage

  • CarboShield Inc. specializes in advanced carbon fiber repair and strengthening solutions for marine piles. Operating within the infrastructure and marine construction market, CarboShield serves clients such as port authorities, marine construction companies, and infrastructure maintenance firms. The company’s core product involves using lightweight, durable carbon fiber half shells that are bonded and fitted around existing pilings, eliminating the need for heavy equipment or underwater work. This innovative approach not only repairs but also strengthens structures, making them more resilient against corrosion, explosions, and seismic forces. CarboShield’s business model revolves around providing engineered structural retrofits that minimize overall costs and disruptions, ensuring customer satisfaction through sustainable and safe practices. Revenue is generated through the sale and installation of these carbon fiber solutions, which are maintenance-free and adaptable to various shapes and cross-sections.

    Early stage · 2–10 employees

  • Carefree Pet

    Wellness & beauty, Food

    Early stage

  • Early stage

  • Cascabel Retreat Center

    Health, Wellness & beauty

    Early stage · 1 employees

  • Early stage · 1 employees

  • Early stage

  • CBR

    Health

    Cord Blood Registry (CBR) operates as a private bank for newborn stem cells, focusing on the collection and cryopreservation of both umbilical cord blood and cord tissue for its clients. CBR's business model is centered on a direct-to-consumer approach, serving expecting parents who choose to privately bank their newborn's stem cells for potential future medical use by the child or compatible family members.Revenue is generated through initial processing fees and recurring annual storage fees. For example, cord blood processing, which includes testing and the first year of storage, is priced around $1,675, with an subsequent annual storage fee of $175. The company's core service involves providing families with a collection kit to be used at the time of birth. The collected cord blood, a source of hematopoietic stem cells (HSCs), and cord tissue, a source of mesenchymal stem cells (MSCs), are then transported to CBR's facility in Tucson, Arizona, for processing and long-term storage. These cells can be used in the treatment of over 80 medical conditions, primarily blood and immune system disorders. A significant aspect of CBR's strategy is its investment in the future applications of stored stem cells. The company actively partners with research institutions to facilitate FDA-regulated clinical trials, giving its client families potential access to emerging therapies for conditions like autism, cerebral palsy, and acquired hearing loss. Notably, a high percentage of stem cell units released by CBR have been for use in experimental regenerative medicine applications. CBR also provides resources such as the Family Health Registry to connect client families with relevant clinical trials. Over its history, CBR has undergone several ownership changes, including acquisitions by AMAG Pharmaceuticals in 2015 for $700 million and later by private equity firm GI Partners in 2018, which merged it with California Cryobank. It now operates under the umbrella of Generate Life Sciences, which was subsequently acquired by CooperCompanies.

    Breakout · 51–200 employees · $18.0M raised

  • CDEX

    Health, Security

    CDEX Inc. is a leading online wholesaler specializing in children's backpacks. The company operates primarily in the e-commerce sector, focusing on providing a wide range of backpack styles, from the latest trends to classic designs. CDEX Inc. also offers customization options, allowing clients to tailor products to specific needs. The primary clients of CDEX Inc. are retailers and distributors who purchase backpacks in bulk to resell in their own stores or online platforms. By targeting these business-to-business (B2B) clients, CDEX Inc. ensures a steady demand for its products, as backpacks are a staple item for school-aged children.CDEX Inc. operates in the wholesale market, which means it sells products in large quantities at lower prices per unit compared to retail prices. This business model allows the company to benefit from economies of scale, reducing costs and increasing profitability. Clients are encouraged to apply to become distributors to take full advantage of these wholesale prices.The company makes money by selling backpacks in bulk to its clients. The revenue model is straightforward: purchase backpacks from manufacturers at a lower cost and sell them at a marked-up price to retailers and distributors. This markup covers operational costs and generates profit. Additionally, CDEX Inc. often runs sales and promotions to attract more clients and increase sales volume.In summary, CDEX Inc. is a specialized online wholesaler of children's backpacks, serving retailers and distributors in the e-commerce sector. The company leverages a bulk sales model to offer competitive prices and customization options, ensuring a steady revenue stream and profitability.

    Early stage · 11–50 employees

  • Early stage · 1 employees

  • Cedr HR Solutions

    Health, Legal

    Early stage · 11–50 employees

  • Early stage

  • Centrum

    Health, Food

    Early stage · 2–10 employees

  • Early stage

  • Early stage

  • CHELLY

    Food

    Early stage · 11–50 employees

  • Early stage

  • CIAN

    Semiconductors

    Late stage · 10001+ employees

  • ClaraDx

    Health

    ClaraDx provides an AI-powered clinical decision support tool built using the professional framework of the Merck Manual. The platform is designed for licensed healthcare professionals such as nurse practitioners, physician assistants, and telemedicine clinicians, as well as medical students. ClaraDx aims to streamline the clinical assessment process, delivering a comprehensive workup in under 60 seconds from a single patient presentation. The core service generates a full clinical assessment that includes an ICD-10 coded differential diagnosis, a pre-populated SOAP note, a drug interaction checker, and a professional referral letter. It also integrates 10 validated clinical scoring tools, such as Wells PE/DVT and the HEART Score, which are automatically triggered based on the patient's chief complaint. The tool is designed to be used on any device with a modern browser without requiring an application installation. For pediatric cases, the system offers features like weight-based dosing and age-appropriate differentials. The business model is subscription-based, with an introductory price of $9.95 per month. ClaraDx offers a free trial that includes one full diagnosis without requiring a credit card, allowing potential users to evaluate the service. The company provides a 30-day money-back guarantee for new subscribers. According to its privacy policy, ClaraDx processes clinical inputs using its AI provider, Anthropic, Inc., but does not store personally identifiable patient information and is not designed to function as a medical records system.

    Early stage · 1 employees

  • Early stage

  • ClearPath Receivables

    Fintech, Enterprise software

    ClearPath Receivables operates as a corporate intelligence firm that develops and manages custom artificial intelligence solutions centered on the order-to-cash (O2C) process. The firm is backed by a network of CFOs and CIOs and led by founder Isiah. Rather than selling standardized software, the company builds bespoke intelligence programs designed to integrate with a client's existing accounting systems, including platforms like NetSuite, QuickBooks, SAP, and Xero. The firm's business model is structured as a managed service, focusing on delivering a complete solution from data preparation through AI deployment and ongoing management. A primary differentiator is the initial phase of data cleansing; ClearPath prepares and reconciles a company’s financial data—addressing issues like unapplied payments and credits—before implementing any AI. This ensures the AI models are built on accurate data, which the company states is critical for generating reliable outcomes. The service is designed to enhance cash flow, lower Days Sales Outstanding (DSO), and reduce operational costs for its clients, which typically include CFOs, controllers, and accounts receivable managers. Key features of the custom AI programs include automated payment matching, intelligent dunning, customer risk scoring, and payment prediction. Beyond operational efficiency, ClearPath transforms raw receivables data into actionable sales and customer intelligence reports, providing insights into customer payment behaviors, churn risk, and revenue patterns. The company positions itself as an alternative to both AI software vendors that don't handle data preparation and traditional accounting firms that don't build AI, offering a managed intelligence solution that provides high-level expertise for the cost of an accounts receivable manager.

    Early stage · 1 employees

Recent venture rounds

CompanyRoundAmountDateInvestors
World View EnterprisesLate VC$10.0MMar 2026Ondas Holdings
KeysEarly VCUndisclosedMar 2026Not disclosed
Revolute RoboticsSeed$1.9MOct 2025ANIMO Ventures, Ascend VC
Delta Development TeamSeries AUndisclosedAug 2025Pasadena Angels, Desert Angels, Central Texas Angel Network +3 more
TYBSeries A$11.0MJun 2025Coinbase Ventures, Unusual Ventures, Castle Island Ventures +2 more
T&R Recovery GroupGrowth Equity VCUndisclosedJun 2025Cyprium Investment Partners, Genesis Park
Branch TherapeuticsSeed$4.0MMay 2025GKCC
SorbiforceSeed$270KApr 2025StartEngine
Precision EpigenomicsSeries A$1.5MSep 2024Shaffer Capital
World View EnterprisesLate VC$25.0MMay 2024Breakthrough Victoria
Investors based here
Accelerators and programs

Source: Dealroom, data as of Oct 1, 2026. Venture funding sums venture-type rounds with a disclosed amount; rounds raised by companies already public or bought out are left out. The last 12 months run from Nov 2025 to Oct 2026.

Founders, team members and individual investors are never shown, and company descriptions have sentences naming people removed.